DK0971713T3 - Anvendelse af cholinesteraseinhibitorer til behandling af opmærksomhedsforstyrrelser - Google Patents

Anvendelse af cholinesteraseinhibitorer til behandling af opmærksomhedsforstyrrelser

Info

Publication number
DK0971713T3
DK0971713T3 DK98905121T DK98905121T DK0971713T3 DK 0971713 T3 DK0971713 T3 DK 0971713T3 DK 98905121 T DK98905121 T DK 98905121T DK 98905121 T DK98905121 T DK 98905121T DK 0971713 T3 DK0971713 T3 DK 0971713T3
Authority
DK
Denmark
Prior art keywords
cholinesterase inhibitors
attention disorders
treat attention
treat
attention
Prior art date
Application number
DK98905121T
Other languages
Danish (da)
English (en)
Inventor
Sharon L Rogers
Lawrence T Friedhoff
Paul J Tiseo
Original Assignee
Eisai Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai Co Ltd filed Critical Eisai Co Ltd
Application granted granted Critical
Publication of DK0971713T3 publication Critical patent/DK0971713T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK98905121T 1997-03-03 1998-03-03 Anvendelse af cholinesteraseinhibitorer til behandling af opmærksomhedsforstyrrelser DK0971713T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3983297P 1997-03-03 1997-03-03
PCT/IB1998/000508 WO1998039000A1 (en) 1997-03-03 1998-03-03 Use of cholinesterase inhibitors to treat disorders of attention

Publications (1)

Publication Number Publication Date
DK0971713T3 true DK0971713T3 (da) 2003-09-22

Family

ID=21907565

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98905121T DK0971713T3 (da) 1997-03-03 1998-03-03 Anvendelse af cholinesteraseinhibitorer til behandling af opmærksomhedsforstyrrelser

Country Status (12)

Country Link
US (2) US6455544B1 (de)
EP (1) EP0971713B1 (de)
JP (1) JP4095676B2 (de)
AT (1) ATE241358T1 (de)
AU (1) AU743609B2 (de)
CA (1) CA2282654C (de)
DE (1) DE69815090T2 (de)
DK (1) DK0971713T3 (de)
ES (1) ES2200313T3 (de)
NZ (1) NZ337515A (de)
PT (1) PT971713E (de)
WO (1) WO1998039000A1 (de)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE241358T1 (de) * 1997-03-03 2003-06-15 Eisai Co Ltd Verwendung von cholinesterasehemmer zur behandlung von konzentrationsstörungen
GB9716879D0 (en) * 1997-08-08 1997-10-15 Shire Int Licensing Bv Treatment of attention deficit disorders
US6429207B1 (en) 1997-11-21 2002-08-06 Nps Pharmaceuticals, Inc. Metabotropic glutamate receptor antagonists and their use for treating central nervous system diseases
EP1764101A1 (de) * 2000-03-03 2007-03-21 Eisai R&D Management Co., Ltd. Verwendung eines Cholinesterasehemmers zur Behandlung von Demenz und Beinträchtigung der Wahrnehmung
DE60124730T2 (de) 2000-03-03 2007-10-04 Eisai R&D Management Co., Ltd. Neue methoden unter verwendung von cholinesteraseinhibitoren
US20060183776A9 (en) * 2000-03-03 2006-08-17 Eisai Co., Ltd. Liquid dosage formulations of donepezil
US20030153598A1 (en) * 2000-07-25 2003-08-14 Raymond Pratt Methods for treating Parkinson's disease with cholinesterase inhibitors
CA2428971A1 (en) * 2000-11-14 2003-05-01 New River Pharmaceuticals Inc. Conjugates of a therapeutic agent and a peptide carrier
US20070053976A1 (en) * 2002-05-17 2007-03-08 Eisai R & D Management Co., Ltd. Novel combination of drugs as antidepressant
WO2004034963A2 (en) * 2002-05-17 2004-04-29 Eisai Co., Ltd. Methods and compositions using cholinesterase inhibitors
US7589199B2 (en) 2002-06-12 2009-09-15 Chemocentryx, Inc. Substituted piperazines
US20050256130A1 (en) * 2002-06-12 2005-11-17 Chemocentryx, Inc. Substituted piperazines
CN1867336B (zh) 2002-06-12 2010-05-12 凯莫森特里克斯股份有限公司 1-芳基-4-取代的哌嗪衍生物及其制药用途
US7842693B2 (en) * 2002-06-12 2010-11-30 Chemocentryx, Inc. Substituted piperazines
US20050232990A1 (en) * 2003-12-31 2005-10-20 Garth Boehm Donepezil formulations
CN1950082B (zh) * 2004-03-03 2013-02-06 凯莫森特里克斯股份有限公司 双环和桥连的含氮杂环化物
US7435831B2 (en) * 2004-03-03 2008-10-14 Chemocentryx, Inc. Bicyclic and bridged nitrogen heterocycles
US7795438B2 (en) 2004-04-28 2010-09-14 Eisai R&D Management Co., Ltd Processes for producing 1-benzyl-4-[(5,6-dimethoxy-1indanon)-2-yl]methylpiperidine and hydrochloride
US20060079558A1 (en) * 2004-09-27 2006-04-13 Bridge Pharma. Inc. R-isomer of 2-{2[N-(2-indanyl)-N-phenylamino]ethyl}piperidine and other dermal anesthetics
US7718674B2 (en) * 2004-09-27 2010-05-18 Bridge Pharma, Inc. Methods of relieving neuropathic pain with the S-isomer of 2-{2[N-(2-indanyl)-N-phenylamino]ethyl}piperidine
JP2008518955A (ja) 2004-11-02 2008-06-05 ノースウェスタン ユニバーシティ ピリダジン化合物および方法
AU2006209216A1 (en) * 2005-01-25 2006-08-03 Galenea Corp Substituted arylamine compounds and their use as 5-HT6 modulators
PL1871368T3 (pl) * 2005-04-04 2011-12-30 Eisai R&D Man Co Ltd Związki dihydropirydynowe do zastosowania w chorobach neurodegeneracyjnych i demencji
AU2006300492B2 (en) * 2005-10-14 2011-08-25 Eisai R & D Management Co., Ltd. Process for producing 1-benzyl-4-[(5,6-dimethoxy-1indanon)-2-yl]methylpiperidine or hydrochloride thereof
CN101410374A (zh) * 2005-11-14 2009-04-15 麦迪凯姆股份公司 用于制备盐酸多奈哌齐的中间体和其新多晶型物的改良的合成和制备
WO2007127474A2 (en) 2006-04-28 2007-11-08 Northwestern University Compositions and treatments using pyridazine compounds and cholinesterase inhibitors
WO2008011161A2 (en) * 2006-07-21 2008-01-24 Bridge Pharma, Inc. Dermal anesthetic compounds
US20080131491A1 (en) * 2006-12-01 2008-06-05 Akinori Hanatani Percutaneously absorbable preparation
WO2008066184A1 (fr) * 2006-12-01 2008-06-05 Nitto Denko Corporation Procédés destinés à prévenir la coloration dans une préparation d'adhésif cutané contenant du donépézil, procédés de réduction de la production d'analogue de donépézil dans une préparation d'adhésif cutané
EP2131828A2 (de) * 2007-03-05 2009-12-16 Eisai R&D Management Co., Ltd. Ampa- und nmda-rezeptorantagonisten für neurodegenerative erkrankungen
US20100130537A1 (en) * 2007-04-26 2010-05-27 Eisai R&D Management Co., Ltd Cinnamide compounds for dementia
KR100914691B1 (ko) * 2007-08-10 2009-08-28 주식회사유한양행 도네페질 또는 그의 제조용 중간체의 제조방법
KR20110011650A (ko) * 2008-05-30 2011-02-08 닛토덴코 가부시키가이샤 도네페질 함유 부착 제제 및 그 포장체
CN102046171B (zh) * 2008-05-30 2013-06-19 日东电工株式会社 经皮吸收制剂
BR112012019923A2 (pt) 2010-02-09 2016-08-09 Univ Johns Hopkins métodos e composições para melhorar a função cognitiva
EP2642998B1 (de) 2010-11-24 2020-09-16 The Trustees of Columbia University in the City of New York Non-retinoider rbp4-antagonist zur behandlung von altersbedingter makuladegeneration und morbus stargardt
US9333202B2 (en) 2012-05-01 2016-05-10 The Trustees Of Columbia University In The City Of New York Non-retinoid antagonists for treatment of age-related macular degeneration and stargardt disease
JP6440625B2 (ja) 2012-11-14 2018-12-19 ザ・ジョンズ・ホプキンス・ユニバーシティー 精神分裂病を処置するための方法および組成物
US9265458B2 (en) 2012-12-04 2016-02-23 Sync-Think, Inc. Application of smooth pursuit cognitive testing paradigms to clinical drug development
US9380976B2 (en) 2013-03-11 2016-07-05 Sync-Think, Inc. Optical neuroinformatics
US9637450B2 (en) 2013-03-14 2017-05-02 The Trustees Of Columbia University In The City Of New York Octahydrocyclopentapyrroles, their preparation and use
WO2014151959A1 (en) 2013-03-14 2014-09-25 The Trustees Of Columbia University In The City Of New York N-alkyl-2-phenoxyethanamines, their preparation and use
ES2705247T3 (es) 2013-03-14 2019-03-22 Univ Columbia 4-fenilpiperidinas, su preparación y uso
US9944644B2 (en) 2013-03-14 2018-04-17 The Trustees Of Columbia University In The City Of New York Octahydropyrrolopyrroles their preparation and use
WO2014144663A1 (en) 2013-03-15 2014-09-18 The Johns Hopkins University Methods and compositions for improving cognitive function
AU2014228512A1 (en) 2013-03-15 2015-10-01 Agenebio, Inc. Methods and compositions for improving cognitive function
US9434727B2 (en) 2014-04-30 2016-09-06 The Trustees Of Columbia University In The City Of New York Substituted 4-phenylpiperidines, their preparation and use
KR101732776B1 (ko) * 2014-10-08 2017-05-04 영남대학교 산학협력단 신규한 인데노 피리디니움 유도체 화합물 및 이의 제조방법
NZ738682A (en) 2015-05-22 2022-01-28 Agenebio Inc Extended release pharmaceutical compositions of levetiracetam

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI95572C (fi) * 1987-06-22 1996-02-26 Eisai Co Ltd Menetelmä lääkeaineena käyttökelpoisen piperidiinijohdannaisten tai sen farmaseuttisen suolan valmistamiseksi
US5064858A (en) * 1988-08-17 1991-11-12 Spectrum Pharmaceutical Corporation Protected complex of procaine for the treatment of symptoms from narcotics addiction, tinnitus and Alzheimer's disease
KR19990028983A (ko) * 1995-07-14 1999-04-15 피터 제이. 코젠스 디-트레오-메틸페니데이트 및 다른 약품으로 이루어진 조성물
RU2190603C2 (ru) * 1996-06-07 2002-10-10 Эйсай Ко., Лтд. Полиморфные модификации донепезила гидрохлорида, способы их получения и способ лечения заболевания, сопровождающегося активностью ацетилхолинэстеразы
ATE241358T1 (de) * 1997-03-03 2003-06-15 Eisai Co Ltd Verwendung von cholinesterasehemmer zur behandlung von konzentrationsstörungen

Also Published As

Publication number Publication date
US6455544B1 (en) 2002-09-24
US20030055040A1 (en) 2003-03-20
CA2282654C (en) 2009-02-03
AU7321598A (en) 1998-09-22
ATE241358T1 (de) 2003-06-15
WO1998039000A1 (en) 1998-09-11
JP2001515480A (ja) 2001-09-18
US7105540B2 (en) 2006-09-12
NZ337515A (en) 2002-07-26
DE69815090D1 (de) 2003-07-03
ES2200313T3 (es) 2004-03-01
PT971713E (pt) 2003-09-30
DE69815090T2 (de) 2004-02-19
EP0971713A1 (de) 2000-01-19
CA2282654A1 (en) 1998-09-11
EP0971713B1 (de) 2003-05-28
AU743609B2 (en) 2002-01-31
JP4095676B2 (ja) 2008-06-04

Similar Documents

Publication Publication Date Title
DK0971713T3 (da) Anvendelse af cholinesteraseinhibitorer til behandling af opmærksomhedsforstyrrelser
DE69924641D1 (de) Behandlung von asthma anhand von mek-inhibitoren
TR200102499T2 (tr) Neoplazi tedavisinde bir kombinasyon terapisi olarak bir siklooksijenaz-2 inhibitörü ve bir veya daha fazla antineoplastik ajan kullanma yöntemi
TR200000755T2 (tr) Karşıt olma-karşı gelme bozukluğunun tedavisi.
DE60319364D1 (de) Substituierte pyrroline als kinase inhibitoren
TR200200204T2 (tr) MEK inhibitörleri kullanılarak kronik ağrının tedavi edilmesi.
DE69837295D1 (de) Probucolbernsteinsäureester zur Hemmung der Expression von VCAM-1
ATE298566T1 (de) Proteintyrosine-kinaseinhibitoren zur behandlung der osteoarthritis
EA200000351A1 (ru) Лечение кондуктивных нарушений
ATE193647T1 (de) Di- und trivalente kleine moleküle als selektininhibitoren
DK0946166T3 (da) Anvendelse af matrixmetalloproteinaseinhibitorer til fremme af sårheling
DE69814444D1 (de) Kombination von angiotensing-convertin-enzyme hemmern mit diuretikum zur behandlung von störungen der mikrozirkulation
DK1001761T3 (da) Anvendelse af cholinesteraseinhibitorer til behandling af opmærksomhedsunderskudslidelser
TR199901703T2 (xx) Siklooksijenaz-2 inhibit�rlerini anti-anjiyojenik ajanlar olarak kullanma y�ntemi.
DE60101559D1 (de) Benutzung von comt-inhibitoren als analgetika
DE69912743D1 (de) Behandlung von follikulären lymphomen unter verwendung von inhibitoren des lymphotoxin (lt)-aktivierungsweges
DE60329326D1 (de) Tace inhibitoren
EA200100930A1 (ru) Способ лечения хозл
EA200001140A1 (ru) СОЕДИНЕНИЯ-ИНГИБИТОРЫ sPLA2 ДЛЯ ЛЕЧЕНИЯ БОЛЕЗНИ
DK1455770T3 (da) Anvendelse af norepinephringenoptagelsesinhibitorer til behandling af tic lidelser
ATE377586T1 (de) Tripeptidylpeptidaseinhibitoren
ATE270113T1 (de) Zusammenstellungen zur verbesserten wundheilung
DE69429013D1 (de) Verwendung von dimeticon zur behandlung der konstipation
ATE291434T1 (de) Verwendung von angiotensin zur behandlung von krebsmetastasierung
BR0314364A (pt) Uso de inibidores de pde iv para tratar angiogênese